Panacea Pharmaceuticals, Inc. President/CEO Interviewed on CEOcast.com

New Developments Supporting Cancer Platform Technology are Presented

ROCKVILLE, Md.--(BW HealthWire)--Aug. 29, 2000--Panacea Pharmaceuticals, Inc. is pleased to announce that its President and CEO, Hossein A. Ghanbari, Ph.D., was interviewed today by CEOcast, Inc., the premier source of original and syndicated streaming broadcast interviews of CEOs at public and private news-making companies.

During the interview, Dr. Ghanbari gave an overview of the Company's drug development efforts for Parkinson's disease and Alzheimer's disease. Also, new findings on the Company's cancer platform technology were presented, including further evidence in support of PAN-346 for the treatment of brain tumors.

The interview can be accessed at www.CEOcast.com.

About CEOcast

CEOcast, Inc. is a leading on-line resource for professional investors seeking information on emerging growth companies. It interviews CEOs in connection with breaking news stories and earnings announcements. CEOcast's programming is distributed to millions of on-line investors at over 700 financial web sites as well as to more than 20,000 portfolio managers, buy-side analysts, and traders at over 3,300 North American institutions. Content is also disseminated to nearly 7,000 investment research professionals representing more than 425 institutions.

About Panacea Pharmaceuticals

Panacea Pharmaceuticals, Inc. focuses on developing and utilizing protein-based technologies to detect and identify changes associated with and involved in diseases of the central nervous system such as Alzheimer's disease, brain tumors, transmissible spongiform encephalopathies, and Lewy body diseases such as Parkinson's disease. Changes in disease-relevant proteins by altered expression, post-translational modification, and functional variation are utilized to develop diagnostic tests and therapeutic agents.

More information is available at www.PanaceaPharma.com, a web site developed by Ei Web Promotion, a division of eiCommunications.com, Inc. (www.eiCommunications.com), which offers integrated communications and web development solutions for the Information Age.